Literature DB >> 8670178

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells.

V Di Marzo1, L De Petrocellis, N Sepe, A Buono.   

Abstract

Anandamide (arachidonoylethanolamide, AnNH) has been recently proposed as the endogenous ligand at the brain cannabinoid receptor CB1. Two alternative pathways have been suggested for the biosynthesis of this putative mediator in the central nervous system. Here we present data (1) substantiating further the mechanism by which AnNH is produced by phospholipase D (PLD)-catalysed hydrolysis of N-arachidonoylphosphatidylethanolamine in mouse neuroblastoma N18TG2 cells, and (2) suggesting for the first time that AnNH is biosynthesized via the same mechanism in a non-neuronal cell line, mouse J774 macrophages, together with other acylethanolamides and is possibly involved in the control of the immune/inflammatory response. Lipids from both neuroblastoma cells and J774 macrophages were shown to contain a family of N-acylphosphatidylethanolamines (N-aPEs), including the possible precursor of AnNH, N-arachidonoyl-PE. Treatment with exogenous PLD, but not with exogenous phospholipase A2 and ethanolamine, resulted in the production of a series of acylethanolamides (AEs), including AnNH, from both cell types. The formation of AEs was accompanied by a decrease in the levels of the corresponding N-aPEs. Enzymically active homogenates from either neuroblastoma cells or J774 macrophages were shown to convert synthetic N-[3H]arachidonoyl-PE into [3H]AnNH, thus suggesting that in both cells an enzyme is present which is capable of catalysing the hydrolysis of N-aPE(s) to the corresponding AE(s). Finally, as previously shown in central neurons, on stimulation with ionomycin, J774 macrophages also produced a mixture of AEs including AnNH and palmitoylethanolamide, which has been proposed as the preferential endogenous ligand at the peripheral cannabinoid receptor CB2 and, consequently, as a possible down-modulator of mast cells. On the basis of this as well as previous findings it is now possible to hypothesize for AnNH and palmitoylethanolamide, co-synthesized by macrophages, a role as peripheral mediators with multiple actions on blood cell function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670178      PMCID: PMC1217444          DOI: 10.1042/bj3160977

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

Review 1.  N-acylated glycerophospholipids and their derivatives.

Authors:  H H Schmid; P C Schmid; V Natarajan
Journal:  Prog Lipid Res       Date:  1990       Impact factor: 16.195

2.  Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor.

Authors:  L Hanus; A Gopher; S Almog; R Mechoulam
Journal:  J Med Chem       Date:  1993-10-01       Impact factor: 7.446

3.  The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor.

Authors:  K K Kruszka; R W Gross
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

Review 4.  New dawn of cannabinoid pharmacology.

Authors:  W A Devane
Journal:  Trends Pharmacol Sci       Date:  1994-02       Impact factor: 14.819

5.  The effect of long-chain N-acylethanolamines on some membrane-associated functions of neuroblastoma C1300 N18 cells.

Authors:  N M Gulaya; A A Melnik; D I Balkov; G L Volkov; M V Vysotskiy; V E Vaskovsky
Journal:  Biochim Biophys Acta       Date:  1993-11-07

6.  Catabolism of N-acylethanolamine phospholipids by dog brain preparations.

Authors:  V Natarajan; P C Schmid; P V Reddy; H H Schmid
Journal:  J Neurochem       Date:  1984-06       Impact factor: 5.372

7.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Authors:  W A Devane; L Hanus; A Breuer; R G Pertwee; L A Stevenson; G Griffin; D Gibson; A Mandelbaum; A Etinger; R Mechoulam
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

8.  Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines.

Authors:  A Fontana; V Di Marzo; H Cadas; D Piomelli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1995-10       Impact factor: 4.006

9.  Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

Authors:  E Fride; R Mechoulam
Journal:  Eur J Pharmacol       Date:  1993-02-09       Impact factor: 4.432

10.  Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.

Authors:  D G Deutsch; S A Chin
Journal:  Biochem Pharmacol       Date:  1993-09-01       Impact factor: 5.858

View more
  44 in total

1.  Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets.

Authors:  A Berger; G Crozier; T Bisogno; P Cavaliere; S Innis; V Di Marzo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.

Authors:  Amy K Dickason-Chesterfield; Stephanie R Kidd; Steven A Moore; John M Schaus; Bin Liu; George G Nomikos; Christian C Felder
Journal:  Cell Mol Neurobiol       Date:  2006-05-31       Impact factor: 5.046

Review 3.  Endocannabinoids and immune regulation.

Authors:  Rupal Pandey; Khalida Mousawy; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Pharmacol Res       Date:  2009-04-07       Impact factor: 7.658

4.  Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons.

Authors:  Gabor Veress; Zoltan Meszar; Dora Muszil; Antonio Avelino; Klara Matesz; Ken Mackie; Istvan Nagy
Journal:  Brain Struct Funct       Date:  2012-05-22       Impact factor: 3.270

Review 5.  Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation.

Authors:  Robert P Picone; Debra A Kendall
Journal:  Mol Endocrinol       Date:  2015-04-13

Review 6.  Endocannabinoid signalling in innate and adaptive immunity.

Authors:  Valerio Chiurchiù; Luca Battistini; Mauro Maccarrone
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

7.  Anandamide produced by Ca(2+)-insensitive enzymes induces excitation in primary sensory neurons.

Authors:  Angelika Varga; Agnes Jenes; Timothy H Marczylo; Joao Sousa-Valente; Jie Chen; Jonothan Austin; Srikumaran Selvarajah; Fabiana Piscitelli; Anna P Andreou; Anthony H Taylor; Fiona Kyle; Mohammed Yaqoob; Sue Brain; John P M White; Laszlo Csernoch; Vincenzo Di Marzo; Laki Buluwela; Istvan Nagy
Journal:  Pflugers Arch       Date:  2013-10-10       Impact factor: 3.657

Review 8.  The dysregulation of the endocannabinoid system in diabesity-a tricky problem.

Authors:  Thomas Scherer; Christoph Buettner
Journal:  J Mol Med (Berl)       Date:  2009-03-17       Impact factor: 4.599

9.  Genetic manipulation of palmitoylethanolamide production and inactivation in Saccharomyces cerevisiae.

Authors:  Giulio G Muccioli; Angela Sia; Paul J Muchowski; Nephi Stella
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

10.  CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.

Authors:  Balázs Csóka; Zoltán H Németh; Partha Mukhopadhyay; Zoltán Spolarics; Mohanraj Rajesh; Stephanie Federici; Edwin A Deitch; Sándor Bátkai; Pál Pacher; György Haskó
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.